![]() |
![]() |
Legal status
Patent lapsed (non-payment of fees)
(51) | INT.CL. | A61K 31/5383 | (2006.01) |
A61K 31/662 | (2006.01) | ||
A61P 9/10 | (2006.01) |
(11) | Number of the document | 2252300 |
(13) | Kind of document | T |
(96) | European patent application number | 09711944.0 |
Date of filing the European patent application | 2009-02-20 | |
(97) | Date of publication of the European application | 2010-11-24 |
(45) | Date of publication and mention of the grant of the patent | 2016-10-19 |
(46) | Date of publication of the claims translation | 2017-02-10 |
(86) | Number | PCT/US2009/034718 |
Date | 2009-02-20 |
(87) | Number | WO 2009/105675 |
Date | 2009-08-27 |
(30) | Number | Date | Country code |
30903 | 2008-02-22 | US |
(72) |
MASUDA, Esteban, US
SCHMITZ, Jochen, US
|
(73) |
Rigel Pharmaceuticals, Inc.,
1180 Veterans Boulevard, South San Francisco, CA 94080,
US
|
(74) |
Liudmila GERASIMOVIČ,
IĮ "Liudmila Gerasimovič, Patentinis patikėtinis", Vingrių g. 13-42, LT-01141 Vilnius,
LT
|
(54) | 2,4-Pirimidindiaminų panaudojimas aterosklerozės gydymui |
USE OF 2,4-PYRIMIDINEDIAMINES FOR THE TREATMENT OF ATHEROSCLEROSIS |
Payment date | Validity (years) | Amount | |
2023-01-31 | 15 | 289.00 EUR |
Patent lapsed (non-payment of fees) | ||
Invalidation date | 2024-02-20 |